BMC Clinical Pharmacology

Table 11 Determination of MIC and MLC for Piperacillin/Tazobactam

From: Comparative in vitrostudy of the antimicrobial activities of different commercial antibiotic products for intravenous administration

Strain	MIC (μg/ml)			MLC (μg/ml)
	Std	M1	M2	Std	M1	M2
A. baumanii (A. b.) 59	500	500	500	1000	1000	1000
A. baumanii 139	500	500	500	1000	1000	1000
A. baumanii 147	500	500	500	1000	1000	1000
A. baumanii 173	Nd	Nd	Nd	125	125	125
S. faecalis (S. f.)	Nd	Nd	Nd	31.25	31.25	31.25
S. faecalis ATCC 29212	Nd	Nd	Nd	250	250	250
S. faecalis ATCC 319623	1000	1000	1000	>1000	>1000	>1000
E. gallinarum (E. g.)	3.95	3.95	3.95	7.81	7.81	7.81
E. coli (E. c.) 39	Nd	Nd	Nd	7.81	7.81	7.81
E. coli 50	1000	1000	1000
E. coli 69	62.25	62.25	62.25	250	250	250
K. pneumoniae (K. p.) 1	Nd	Nd	Nd	62.51	62.51	62.51
K. pneumoniae 43	R	R	R	R	R	R
K. pneumoniae 63	Nd	Nd	Nd	1000	1000	1000
K. pneumoniae 65	Nd	Nd	Nd	500	500	500
K. pneumoniae 207	R	R	R	R	R	R
Ps. aeruginosa (P. a.) 42	Nd	Nd	Nd	7.81	7.81	7.81
Ps. aeruginosa 74	125	125	125	250	250	250
Ps. aeruginosa 151	31.25	31.25	31.25	62.51	62.51	62.51
Ps. aeruginosa 157	62.51	62.51	62.51	125	125	125
St. aureus (S. a.) 287	Nd	Nd	Nd	7.81	7.81	7.81
St. aureus 291	31.25	31.25	31.25	62.51	62.51	62.51
St. aureus 25923	Nd	Nd	Nd	31.25	31.25	31.25

Back to article page